Vaccine leader Sinovac was cyberbullied, why did the rumors appear?

Vaccine leader Sinovac was cyberbullied, why did the rumors appear? The reason why rumors appear is that some people are deliberately doing things, not wanting to make this society more harmonious and not wanting to make this society better. And some people say that the company started to do real estate after making money, and at present, this leading enterprise is mainly to manage the vaccine, even if it enters the real estate industry in the future, it has nothing to do with the vaccine, so the vaccine is doing well, why do you want to do real estate.

The appearance of this rumor is to make people's hearts panic a little, and then laugh next to it, in fact, these are rumors, don't worry.

Rumors will appear, and someone is deliberately doing something

There are some other reactions to the vaccine, and some people are even besieging the manufacturer of the vaccine. In fact, these are all rumors, why do rumors appear? It's because some people are deliberately spreading rumors to do things, they don't want this society to develop harmoniously, and they don't want this society to become better.

Our leaders also have some well-known leaders of major corporations, and they are all vaccinated, so the safety and necessity are obvious, so stop spreading rumors.

What this company does has nothing to do with the people who vaccinate

Some people say that after this company makes money, it will go to real estate, or go to other businesses, and what this company does has nothing to do with us, as long as the vaccine it produces is intact and safe, we can get it. Take 10,000 steps back, even if this company enters the real estate industry in the future, does it have anything to do with vaccines? So we don't need to worry about others, we just need to make sure that the vaccine is good and we can get it.

Rumors appeared, confusing people's hearts

Since ancient times, there are good people and bad people, some people are not used to the harmonious development of this society, why do these rumors appear frequently, they just want to confuse people's hearts a little, and then look at our jokes on the side, it is very likely that some lawbreakers are deliberately doing things, so don't worry about rumors and don't spread rumors.

Because some people have some complications. But this has nothing to do with vaccines, but it is being used by people with intentions.

This vaccine made a lot of money in our country, and then someone thought that they were going to start a real estate business.

The main thing is that there are some individual cases that appear, and then they disturb the social order, and then rumors appear.

Sinovac, which produces vaccines.

Zhongwei's largest shareholder is Sinovac (Hong Kong), and there are several smaller shareholders. The two shareholders of Sinovac Biotech are Sinovac (Hong Kong) and Weiming Pharmaceutical.

Extended information: 1. Sinovac.

Beijing Sinovac is a bio-fiber high-tech enterprise jointly established by Shenzhen Kexing Bioengineering Co., Ltd., Tangshan Yi'an Bioengineering, and Hong Kong Huading Pharmaceutical. In 2001, it was established in Zhongguancun Science and Technology Park, Beijing.

Incorporation with registered capital.

100 million yuan, the total investment of Gongsun Dousi is 100 million yuan. The purpose of the establishment and operation of the company: in line with the desire to develop China's bioengineering high-tech industry, adopt advanced scientific and technological achievements at home and abroad, and introduce international scientific management methods, carry out research, production and sales of human vaccines and related products, provide technical advice and technical services, and then improve domestic and foreign understanding of hepatitis A and B.

and contribute to human health.

2. Unnamed medicine.

Founded on December 10, 1998, its business scope includes biotechnology research, development, production and sales of self-produced products of biological products and corresponding high-tech products, technology transfer, technical consulting and technical services for bioengineering.

3. Shareholders. 1. The shareholder is the investor or investor of the joint-stock company.

2. It can be divided into institutional shareholders and individual shareholders as shareholders. Institutional shareholders refer to legal persons and other organizations that enjoy shareholder rights. Institutional shareholders include all kinds of companies, all kinds of national and collective ownership enterprises, all kinds of non-profit legal persons and ** institutions and organizations.

Individual shareholders refer to general natural person shareholders.

3. A shareholder is a person who holds shares in a joint-stock company or a limited liability company and has the right to attend the general meeting of shareholders.

and has voting rights, and also refers to investors in other joint ventures.

4. The legal status of shareholders.

1. In terms of the relationship between shareholders and the company, shareholders, as capital contributors, enjoy the rights of the owner to share the benefits, make major decisions and choose managers according to the amount of their capital contributions (unless otherwise agreed by the shareholders).

2. In terms of the relationship between shareholders, the status of shareholders is equal, and in principle, the same shares have the same rights and the same benefits, but the articles of association of the company.

Other agreements may be made.

Note: Wholly state-owned company.

It should be *** or local people**.

Entrust the people's state-owned assets supervision and administration institutions at the same level to perform the duties of investors.

When the story was becoming more and more bizarre, Sinovac finally responded and established Yidao Real Estate, if nothing else, to build collective land rental housing in Daxing, Beijing, to solve the accommodation problem of employees.

The rumor-mongers are clearly overestimating their own IQ and underestimating Sinovac's IQ at the same time. Nowadays, the real estate industry is relatively sluggish, if you really want to enter the real estate, it is not more efficient to directly acquire a fully qualified brand real estate, why bother to set up your own company.

Moreover, it is completely inconsistent with the basic logic of business operation to let Sinovac abandon the familiar industry of high technology, high threshold and high income, and switch to the real estate industry with high investment and low returns, and there is no reason to make Sinovac abandon its roots.

Now even more disappointed than the rumor-mongers are probably the front-line employees of Sinovac. In this statement, Sinovac announced that it would cancel the real estate company, no longer build its own rental housing, and solve the problem of employee accommodation in the future.

Strong evidence and strong measures should be given so that everyone can believe it.

1. The cause of death of Sinovac executives was due to ineffective medical treatment due to illness. Cao Xiaobin, senior manager of Beijing Sinovac Bioproducts ****** Affairs Center, passed away on April 17, 2022 at the age of 45 due to ineffective medical treatment. Cao Xiaobin was born in June 1976 and graduated from the Chinese Center for Disease Control and Prevention with a doctorate degree in epidemiology and health statistics.

Since joining the work, he has been engaged in disease control and prevention and control work.

2. The specific cause of death of Sinovac executives is said to be bile duct cancer. In mid-March 2022, Cao Xiaobin went to the hospital due to physical discomfort and called Zhizhi, and was later diagnosed with advanced cholangiocarcinoma with multiple metastases, missing the best opportunity. Cholangiocarcinoma is a malignant tumor originating from bile duct epithelial cells, which is characterized by strong aggressiveness and poor prognosis, and the incidence of cholangiocarcinoma accounts for about 3% of gastrointestinal tumors.

It is more common in men between the ages of 50 and 70.

3. Sinovac caused leukemia is a rumor, and there are voices on the Internet that he suffered from leukemia after receiving the new crown vaccine. Wang Huaqing, chief expert of the immunization program of the Chinese Center for Disease Control and Prevention, said that whether some symptoms and diseases appear after vaccination are related to vaccination or not, relevant judgments need to comply with standardized procedures and have a basis. If there is any suspicion, it should be reported to the vaccination unit, and the vaccination unit will form a multi-disciplinary expert group to collect relevant information.

2022 is not even halfway through, and Sinovac, the seat of the top ten rumors of the year, has been "booked" for two seats. At the beginning of the year, news such as "Sinovac enters real estate" and "The end of the universe is Beijing Sinovac's real estate" became popular. The reason is that some netizens found that Sinovac has newly established a wholly-owned subsidiary called Beijing Kexing Yiyi Real Estate.

This incident has caused a lot of interpretations, such as "real estate is a siege, people inside want to go out, and people outside want to come in". The script of "Vaccine Boss" entering real estate made netizens shout wonderful, and it also made Sinovac cry and laugh.

Before being exposed to the year-end bonus, Kezhongwei had laid off a large number of employees. What is the real situation? What is the official response to this?

I have the impression that the anti-infection rate of Likexin seems to be only more than 20%, which is also much lower than that of Pfizer. I remember that Pfizer was 50% to 60% (not necessarily accurate, it varies widely). In the comparison of vaccines, Sinovac's results are at the bottom, but for the protection of severe cases, Sinovac is only slightly lower than Pfizer, and the difference between the two is very small, both above 80%.

On the last day of 2021 (December 31), Sinovac Biotech released its financial report for the second half of 2021.

From this financial report, we can see that Sinovac's performance has achieved unprecedented improvement, which can no longer be described by the word "skyrocketing". The promotion of vaccines made Sinovac earn 30 billion in half a year, and the shareholding structure was exposed. At the same time, it caused objections, and the controlling shareholder behind it was actually foreign capital.

When the story became more and more bizarre, Sinovac finally responded and set up a real estate, if nothing else, to build collective land rental housing in Beijing to solve the accommodation problem of employees. The rumor-mongers clearly overestimated their own IQ and underestimated Sinovac's IQ.

Now the real estate sector is sluggish. If you really want to enter the real estate industry, it will be more efficient to directly acquire a well-qualified brand real estate. Why start your own company?

It is reasonable to say that Sinovac started laying off employees after making huge profits in the first two years because the company has been pessimistic about the future sales of its vaccines. (Haven't you heard of China's vaccine exports for a long time When the Sinovac vaccine market was hot, Sinovac estimated that it recruited a large number of people to expand production.)

Because the future sales expectations are not good now, layoffs are made in advance.

Sinovac vaccine belongs to Beijing Sinovac Biotech****. Founded in 2009, Beijing Sinovac Biotechnology Co., Ltd. is a biological high-tech company, which belongs to Beijing Sinovac Holding Co., Ltd., which mainly researches the development, production and technical support of human vaccines and related products, and provides technical support for serious infectious diseases.

Beijing Sinovac****.

Beijing Keqin regrets Zhaoxing **** is SVA. Beijing Sinovac is listed on the NASDAQ market and owns four wholly-owned subsidiaries: Beijing Sinovac Biological Products, Sinovac (Dalian) Vaccine Technology, Beijing Sinovac Zhongwei Biotechnology, and Beijing Sinovac Zhongyi Biomedical. The company mainly provides technical support for human vaccine research and develops related vaccine products, including vaccine development, sales and production.

The company has developed a variety of vaccine products, such as a new drug for the prevention of biological products - enterovirus 71 inactivated vaccine.

If you play a shaped limb, Sinovac Zhongwei will not be compensated. However, if the damage caused by Sinovac is related to the vaccine, you can apply for compensation. Legal Analysis:

Dear, if you are damaged by Sinovac, there is compensation, and the national compensation system is applicable to accidents that occur in the process of national vaccination. If you have an accident after vaccination, you (or your guardian) can apply for compensation at the jurisdiction of your residence** after preparing the application procedures for compensation. After receiving the compensation application, the Centers for Disease Control and Prevention will decide the compensation within 120 days after the compensation review by the Vaccination Compensation Committee.

According to the national compensation standard, the new crown vaccine is mainly based on the payment of compensation, and the death of SI caused by vaccination problems can apply for state compensation, but it needs to be applied for in accordance with the national compensation process. Legal basis: Article 63 of the Vaccine Administration Law of the People's Republic of China Article 63 The people at or above the county level shall include the funds required for vaccine safety work, the purchase of immunization program vaccines and immunization work, and the construction of informatization into the budget at the same level.

For those suspected of being injured by vaccination and undergoing pathological dissection, the funeral subsidy is 300,000 yuan, 500,000 yuan to 6 million yuan for those who are suspected of being injured by vaccination, and 300,000 to 3,500,000 yuan for those who cannot be determined to have caused SI due to vaccination, and up to 6 million yuan if physical and mental disabilities or serious diseases occur as a result.

The Sinovac vaccine was developed by Beijing Sinovac Biologics. The vaccine developed by the company has been on the market, and has been used urgently in many other countries, it is also effective for the mutant new coronavirus, can prevent the mutant virus in many other countries, protect the health of many people, and avoid people from physical diseases caused by the virus.

R&D process. The general process and cycle of vaccine development include two stages:

The first stage is the pre-vaccine research and development process, including the acquisition of immunogen (obtaining live virus, isolating relevant subunits, obtaining recombinant proteins or synthesizing related DNA (RNA) through genetic recombination technology), immune response testing, animal protection testing, immunogen production process (amplification) optimization, preclinical toxicology research, etc.

The second stage is the vaccine development and registration process, including preclinical research, clinical application, clinical trials, and finally the launch of the vaccine.